This activity is supported by an unrestricted educational grant from Icometrix and Biogen.
Moderator: Tammie Benzinger, MD, PhD
Speakers: Ana Franceschi, MD and Jon McConathy, MD
Upon completion of this activity, participants will have strategies to:
-- Describe the use of molecular imaging biomarkers in diagnosis of dementia.
-- Explain the shift from a clinical to a biological diagnosis of neurodegenerative disease.
-- Understand the trajectory of the Alzheimer's drug development pipeline.
-- Describe the basic reading criteria for clinical amyloid and tau PET interpretation.
-- Understand the clinical implications of negative and positive amyloid and tau PET studies.
-- Recognize how neuroimaging contributes to the AT(N) framework for defining Alzheimer’s disease.
CME credit is available for the live AND recorded webinar versions through the ASNR Education Connection website. Visit http://asnr.mycrowdwisdom.com, launch the course from the catalog, and complete a brief survey. CME certificates will be listed on the MY LEARNING - COMPLETED page after the survey is completed.
The American Society of Neuroradiology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Society of Neuroradiology designates this enduring material for a maximum of 1 "AMA PRA Category 1 Credit"TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.